611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line

NurseWise 24-Hour Crisis Line


611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...

Basic InformationLatest News
ASCO: Capecitabine May Extend Survival in Biliary Tract CancerOverweight Boys Face Higher Colon Cancer Risk as AdultsMore U.S. Women Living With Metastatic Breast CancerASCO: Early Detection of Cancers Up Since Affordable Care ActHPV Vaccine May Also Prevent Cancers Affecting MenChemo Drug May Buy Time for Those With Bile Duct CancerMore U.S. Women Living Longer With Advanced Breast CancerToo Many Americans Still Go Without Cancer ScreeningsNuts! Good Medicine for Colon Cancer Survivors?AUA: E-Cigarettes Can Also Cause DNA Damage to Bladder MucosaE-Cigarettes Linked to Bladder Cancer RiskCould Tai Chi Ease Insomnia in Breast Cancer Survivors?Leukotriene B4 Is Promising Drug Target for Tx of LymphedemaNew VTE Often Occurs During Chemo in Ovarian CancerHope for 1st Drug Against Lymphedema, a Cancer ComplicationPoor Environmental Quality Tied to Higher Cancer RatesTraveling to Academic Hospital May Be Best for Pancreatic CancerNo Routine Screening for Thyroid Cancer: Expert PanelA Movie Instead of Anesthesia for Kids' Radiation TherapyAddressing Your Cancer RiskOsteoporosis Tx Ups Survival in Postmenopausal Breast CancerNot All Hospitals Equal When It Comes to Pancreatic Cancer CareGet Ready for Your 'Capsule Robot' Colon Cancer CheckCervical CA Survivors Often Have Long-Term Fatigue, InsomniaMore Side Effects With CRT Plus Metformin in Head, Neck CancerCervical Cancer May Leave Lasting Imprint on SurvivorsHousehold Income Takes a Hit After Cancer Diagnosis in SpouseLow-Dose Aspirin May Lower Risk for Common Breast Cancer by 20 PercentDrinking Boosts Breast Cancer Risk for Black Women, TooFDA Approves Kinase Inhibitor for Treatment of AMLRydapt Approved for Adults With Acute Myeloid LeukemiaRegorafenib Approved for Hepatocellular CarcinomaStivarga Approved for Liver CancerMoney Pressures Mount When a Spouse Gets CancerGene Expression Profile Improves ID of High-Risk MelanomaFDA Warns Companies Selling Fraudulent Cancer TreatmentsCancer Risk Rises After Childhood Organ Transplant: StudyStudy Says Blood-Chromosome Test Predicts Lung Cancer's ReturnWaiting 10 Months for Colonoscopy May Raise CRC RiskFDA Warns 14 Companies on Bogus Cancer 'Cures'PSA Testing Rates for Prostate Cancer Have Leveled OffShould Prostate Cancer Screening Start Earlier for Black Men?Surveillance Biopsy Timing Not Tied to ReclassificationSecond Cancers Deadlier for Younger People: StudyHypertension May Positively Affect Ovarian Cancer PrognosisASCO Updates Recs on Potentially Curable Pancreatic CancerBreast Cancer Rates Increasing Among Asian-American WomenVaccine-Chemotherapy Combo Promising in GlioblastomaYoga Helps Ease Side Effects of Prostate Cancer TreatmentVaccine Targeting Brain Tumors Seems Safe in Study
LinksBook ReviewsSelf-Help Groups
Related Topics

Medical Disorders
Pain Management

Second Cancers Deadlier for Younger People: Study

HealthDay News
by -- Robert Preidt
Updated: Apr 20th 2017

new article illustration

THURSDAY, April 20, 2017 (HealthDay News) -- When a second cancer strikes, it tends to be far more deadly in the young, a new study reveals.

The findings may help explain the poor outcomes of younger cancer patients overall, the researchers added.

The researchers also found that survival odds for nearly all types of cancer are better for an initial cancer than for a second, unrelated cancer. That difference is greatest among patients younger than 40, the study authors said.

"Although the increased incidence of second cancers is well known among cancer survivors, less is known about outcomes of these cancers or the influence of age," said study author Theresa Keegan.

Keegan is a cancer epidemiologist at the University of California, Davis Comprehensive Cancer Center.

The researchers analyzed 1992-2008 data on more than 1 million cancer patients of all ages in the United States. They then looked for second cancers, meaning a new cancer, not a recurrence.

They found that the five-year survival rate for children and young adults was 80 percent after a first cancer. However, it dropped to 47 percent for children and 60 percent for young adults in cases of second cancers, Keegan and her colleagues said in a university news release.

Meanwhile, survival rates in older adults were 70 percent and 61 percent, respectively.

When the researchers focused on the 14 most common cancer types that affect young adults, they found that for all but two, there were significant survival differences depending on whether it was a first or second cancer.

For example, the five-year survival rate for young adults with acute myeloid leukemia was 57 percent if it was a first cancer, but only 29 percent if it was a second cancer. The five-year survival rate for young adult women with breast cancer was 81 percent if it was a first cancer but only 63 percent if it was a second cancer.

It's not clear why younger patients tend to do worse than older patients with the same second cancers.

But the researchers suggested several possible reasons, including worse response to treatment, limitations on the types or doses of treatments that they can receive as a result of prior cancer treatment, or reduced physical reserves that lower their ability to tolerate treatment.

Mental health and social issues may also be factors.

"These younger people don't have all the support or resources they need," said study co-author Melanie Goldfarb.

"They may not have adequate insurance, or they may get lost in the system. They may suffer from depression, which can contribute to their overall health and worsen their cancer outcome," added Goldfarb, an endocrine surgeon at John Wayne Cancer Institute in Santa Monica, Calif.

The study was published April 20 in the journal JAMA Oncology.

More information

The American Cancer Society has more on second cancers.